Vitang Technology LLC
Letter data
- Company
- Vitang Technology LLC
- Recipient
- Ronald Jiang | Owner & CEO | Vitang Technology LLC | 14622 Franklin Ave Ste H | Tustin | , | CA | 92780-7224 | United States | info@vitangtechnology.com | ron@vitangtechnology.com
- Issue date
- 2024-07-23
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 653455
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Vitang Technology LLC
MARCS-CMS 653455 —
July 23, 2024
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Product:
Medical Devices
Recipient:
Recipient Name
Ronald Jiang
Recipient Title
Owner & CEO
Vitang Technology LLC
14622 Franklin Ave Ste H
Tustin
,
CA
92780-7224
United States
info@vitangtechnology.com
ron@vitangtechnology.com
Issuing Office:
Center for Devices and Radiological Health
United States
Secondary Issuing Offices
United States
Dr. Mr. Jiang,
The Food and Drug Administration has completed an evaluation of your corrective actions in response to Warning Letter #653455 dated 6/12/2023. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Jessica Mu
Compliance Branch Director
Office of Medical Devices and Radiological Health Operations
Division 3/West
Content current as of:
07/31/2024
Regulated Product(s)
Medical Devices